Market Closed -
Japan Exchange
02:00:00 2024-05-21 am EDT
|
5-day change
|
1st Jan Change
|
841
JPY
|
-0.71%
|
|
-3.00%
|
-15.65%
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
13,755
|
9,410
|
32,330
|
20,784
|
18,820
|
20,789
|
-
|
-
|
Enterprise Value (EV)
1 |
14,958
|
10,927
|
32,628
|
20,783
|
18,668
|
22,420
|
20,789
|
20,789
|
P/E ratio
|
14.8
x
|
11.3
x
|
21.7
x
|
11.3
x
|
11.1
x
|
11.2
x
|
8.32
x
|
7.85
x
|
Yield
|
2.53%
|
3.96%
|
1.24%
|
2.4%
|
3.15%
|
2.76%
|
3.21%
|
3.45%
|
Capitalization / Revenue
|
0.33
x
|
0.22
x
|
0.7
x
|
0.43
x
|
0.36
x
|
0.41
x
|
0.36
x
|
0.35
x
|
EV / Revenue
|
0.33
x
|
0.22
x
|
0.7
x
|
0.43
x
|
0.36
x
|
0.41
x
|
0.36
x
|
0.35
x
|
EV / EBITDA
|
5
x
|
3.94
x
|
8.55
x
|
-
|
-
|
4.7
x
|
4.35
x
|
4.06
x
|
EV / FCF
|
21,525,909
x
|
45,024,152
x
|
31,665,500
x
|
-
|
24,441,956
x
|
-
|
-
|
-
|
FCF Yield
|
0%
|
0%
|
0%
|
-
|
0%
|
-
|
-
|
-
|
Price to Book
|
1.31
x
|
0.85
x
|
2.66
x
|
1.53
x
|
1.29
x
|
1.4
x
|
1.14
x
|
1.03
x
|
Nbr of stocks (in thousands)
|
24,829
|
24,829
|
24,966
|
24,981
|
24,699
|
24,719
|
-
|
-
|
Reference price
2 |
554.0
|
379.0
|
1,295
|
832.0
|
762.0
|
841.0
|
841.0
|
841.0
|
Announcement Date
|
5/15/19
|
5/21/20
|
5/14/21
|
5/16/22
|
5/15/23
|
5/15/24
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
41,104
|
43,167
|
45,909
|
48,876
|
52,551
|
54,057
|
57,000
|
59,500
|
EBITDA
1 |
2,749
|
2,387
|
3,781
|
-
|
-
|
4,425
|
4,775
|
5,125
|
EBIT
1 |
1,958
|
1,468
|
2,806
|
2,865
|
2,539
|
3,034
|
3,600
|
3,900
|
Operating Margin
|
4.76%
|
3.4%
|
6.11%
|
5.86%
|
4.83%
|
5.61%
|
6.32%
|
6.55%
|
Earnings before Tax (EBT)
1 |
1,624
|
1,353
|
2,311
|
2,760
|
2,660
|
3,183
|
3,650
|
3,900
|
Net income
1 |
931
|
830
|
1,486
|
1,836
|
1,713
|
2,005
|
2,500
|
2,650
|
Net margin
|
2.26%
|
1.92%
|
3.24%
|
3.76%
|
3.26%
|
3.71%
|
4.39%
|
4.45%
|
EPS
2 |
37.52
|
33.45
|
59.61
|
73.54
|
68.87
|
81.15
|
101.1
|
107.2
|
Free Cash Flow
|
639
|
209
|
1,021
|
-
|
770
|
-
|
-
|
-
|
FCF margin
|
1.55%
|
0.48%
|
2.22%
|
-
|
1.47%
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
23.25%
|
8.75%
|
27.01%
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
68.64%
|
25.18%
|
68.71%
|
-
|
44.95%
|
-
|
-
|
-
|
Dividend per Share
2 |
14.00
|
15.00
|
16.00
|
20.00
|
24.00
|
25.00
|
27.00
|
29.00
|
Announcement Date
|
5/15/19
|
5/21/20
|
5/14/21
|
5/16/22
|
5/15/23
|
5/15/24
|
-
|
-
|
Fiscal Period: March |
2020 S1
|
2020 S2
|
2021 S1
|
2022 Q2
|
2022 S1
|
2022 Q3
|
2022 Q4
|
2022 S2
|
2023 Q1
|
2023 Q2
|
2023 S1
|
2023 Q3
|
2023 Q4
|
2023 S2
|
2024 Q1
|
2024 S1
|
2024 Q3
|
2024 Q4
|
2024 S2
|
2025 Q1
|
2025 Q2
|
2025 Q3
|
2025 Q4
|
---|
Net sales
1 |
21,243
|
21,924
|
22,732
|
11,968
|
23,738
|
12,578
|
12,560
|
25,138
|
13,015
|
13,170
|
26,185
|
13,295
|
13,071
|
26,366
|
13,400
|
26,960
|
13,640
|
13,457
|
27,097
|
14,000
|
14,270
|
14,400
|
14,330
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
787
|
681
|
1,436
|
726
|
1,457
|
936
|
472
|
1,408
|
728
|
647
|
1,375
|
687
|
477
|
1,164
|
785
|
1,611
|
905
|
518
|
1,423
|
840
|
900
|
990
|
870
|
Operating Margin
|
3.7%
|
3.11%
|
6.32%
|
6.07%
|
6.14%
|
7.44%
|
3.76%
|
5.6%
|
5.59%
|
4.91%
|
5.25%
|
5.17%
|
3.65%
|
4.41%
|
5.86%
|
5.98%
|
6.63%
|
3.85%
|
5.25%
|
6%
|
6.31%
|
6.88%
|
6.07%
|
Earnings before Tax (EBT)
|
709
|
-
|
1,424
|
-
|
1,433
|
929
|
-
|
-
|
753
|
637
|
1,390
|
717
|
553
|
1,270
|
786
|
1,688
|
1,001
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
400
|
430
|
1,006
|
468
|
949
|
612
|
275
|
887
|
495
|
398
|
893
|
468
|
352
|
820
|
485
|
1,074
|
693
|
238
|
931
|
580
|
630
|
700
|
590
|
Net margin
|
1.88%
|
1.96%
|
4.43%
|
3.91%
|
4%
|
4.87%
|
2.19%
|
3.53%
|
3.8%
|
3.02%
|
3.41%
|
3.52%
|
2.69%
|
3.11%
|
3.62%
|
3.98%
|
5.08%
|
1.77%
|
3.44%
|
4.14%
|
4.41%
|
4.86%
|
4.12%
|
EPS
|
16.13
|
-
|
40.42
|
-
|
38.01
|
24.51
|
-
|
-
|
19.85
|
-
|
35.77
|
18.81
|
-
|
-
|
19.64
|
43.49
|
28.06
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
11/8/19
|
5/21/20
|
11/9/20
|
11/8/21
|
11/8/21
|
2/8/22
|
5/16/22
|
5/16/22
|
8/8/22
|
11/8/22
|
11/8/22
|
2/8/23
|
5/15/23
|
5/15/23
|
8/8/23
|
11/8/23
|
2/8/24
|
5/15/24
|
5/15/24
|
-
|
-
|
-
|
-
|
Fiscal Period: March |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
1,203
|
1,517
|
298
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
1
|
152
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
0.4377
x
|
0.6354
x
|
0.0788
x
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
639
|
209
|
1,021
|
-
|
770
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
9.1%
|
7.7%
|
12.8%
|
14.3%
|
12.2%
|
13.1%
|
14.5%
|
13.8%
|
ROA (Net income/ Total Assets)
|
7.48%
|
5.89%
|
11.2%
|
10.5%
|
9.5%
|
10.4%
|
11.2%
|
11.3%
|
Assets
1 |
12,439
|
14,087
|
13,262
|
17,435
|
18,028
|
19,229
|
22,321
|
23,451
|
Book Value Per Share
2 |
424.0
|
444.0
|
487.0
|
543.0
|
590.0
|
647.0
|
736.0
|
816.0
|
Cash Flow per Share
|
69.70
|
68.40
|
96.60
|
112.0
|
108.0
|
119.0
|
-
|
-
|
Capex
1 |
1,248
|
2,114
|
1,259
|
1,332
|
1,233
|
1,250
|
1,300
|
1,300
|
Capex / Sales
|
3.04%
|
4.9%
|
2.74%
|
2.73%
|
2.35%
|
2.3%
|
2.28%
|
2.18%
|
Announcement Date
|
5/15/19
|
5/21/20
|
5/14/21
|
5/16/22
|
5/15/23
|
5/15/24
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -15.65% | 134M | | +1.25% | 3.14B | | 0.00% | 1.96B | | +18.47% | 1.79B | | +69.97% | 695M | | -45.94% | 309M | | -19.78% | 170M | | +3.85% | 67.96M |
Home Healthcare Services
|